Nevro Corp Stock Buy Hold or Sell Recommendation
| NVRO Stock | USD 4.55 0.03 0.66% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Nevro Corp is 'Hold'. The recommendation algorithm takes into account all of Nevro Corp's available fundamental, technical, and predictive indicators you will find on this site.
Check out Nevro Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide. In addition, we conduct extensive research on individual companies such as Nevro and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Nevro |
Execute Nevro Corp Buy or Sell Advice
The Nevro recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nevro Corp. Macroaxis does not own or have any residual interests in Nevro Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nevro Corp's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Nevro Corp Trading Alerts and Improvement Suggestions
| Nevro Corp generated a negative expected return over the last 90 days | |
| Nevro Corp has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 425.17 M. Net Loss for the year was (92.21 M) with profit before overhead, payroll, taxes, and interest of 276.37 M. | |
| Nevro Corp currently holds about 310.82 M in cash with (58.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Nevro Corp has a poor financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from massdevice.com: Nevros SI joint fixation system delivers enhanced stability and fusion for patients |
Nevro Corp Returns Distribution Density
The distribution of Nevro Corp's historical returns is an attempt to chart the uncertainty of Nevro Corp's future price movements. The chart of the probability distribution of Nevro Corp daily returns describes the distribution of returns around its average expected value. We use Nevro Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nevro Corp returns is essential to provide solid investment advice for Nevro Corp.
| Mean Return | -0.14 | Value At Risk | -7.61 | Potential Upside | 8.28 | Standard Deviation | 5.02 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nevro Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Nevro Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Nevro Corp, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Nevro Corp back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Millennium Management Llc | 2024-06-30 | 956.5 K | Assenagon Asset Management Sa | 2024-09-30 | 929.3 K | Geode Capital Management, Llc | 2024-09-30 | 835.2 K | Palo Alto Investors, Llc | 2024-09-30 | 750.4 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 732.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 675.5 K | Kent Lake Capital Llc | 2024-06-30 | 639.8 K | Citadel Advisors Llc | 2024-09-30 | 536.1 K | Balyasny Asset Management Llc | 2024-09-30 | 505.3 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-09-30 | 4.4 M | Armistice Capital, Llc | 2024-09-30 | 3.7 M |
Nevro Corp Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (938K) | 2.5M | (17.2M) | (7.8M) | (19.2M) | (20.2M) | |
| Change In Cash | 14.5M | (21.1M) | (9.9M) | 85.7M | (16.2M) | (15.3M) | |
| Free Cash Flow | (53.7M) | (4.8M) | (54.2M) | 17.1M | (67.4M) | (70.8M) | |
| Depreciation | 7.8M | 8.2M | 8.7M | 10.3M | 11.5M | 12.1M | |
| Other Non Cash Items | 7.9M | 14.9M | 13.3M | 3.4M | 4.6M | 7.1M | |
| Capital Expenditures | 3.5M | 6.0M | 12.3M | 7.5M | 8.6M | 5.5M | |
| Net Income | (103.7M) | (83.1M) | (131.4M) | 3.0M | (92.2M) | (87.6M) | |
| End Period Cash Flow | 66.3M | 45.2M | 35.3M | 121.0M | 104.8M | 58.6M | |
| Investments | 43.3M | (371.3M) | 214.1M | 71.8M | (5.6M) | (5.9M) | |
| Change Receivables | (2.2M) | 3.4M | 8.2M | (9.6M) | (11.1M) | (11.6M) | |
| Change To Netincome | 43.1M | 50.2M | 47.1M | 61.3M | 70.5M | 37.1M |
Nevro Corp Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nevro Corp or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nevro Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nevro stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.43 | |
β | Beta against Dow Jones | 2.33 | |
σ | Overall volatility | 5.02 | |
Ir | Information ratio | -0.05 |
Nevro Corp Volatility Alert
Nevro Corp exhibits very low volatility with skewness of 0.36 and kurtosis of 0.37. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nevro Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nevro Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Nevro Corp Fundamentals Vs Peers
Comparing Nevro Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nevro Corp's direct or indirect competition across all of the common fundamentals between Nevro Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nevro Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nevro Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nevro Corp by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nevro Corp to competition |
| Fundamentals | Nevro Corp | Peer Average |
| Return On Equity | -0.25 | -0.31 |
| Return On Asset | -0.0902 | -0.14 |
| Profit Margin | (0.17) % | (1.27) % |
| Operating Margin | (0.16) % | (5.51) % |
| Current Valuation | 138.92 M | 16.62 B |
| Shares Outstanding | 37.47 M | 571.82 M |
| Shares Owned By Insiders | 3.71 % | 10.09 % |
| Shares Owned By Institutions | 98.09 % | 39.21 % |
| Number Of Shares Shorted | 3.14 M | 4.71 M |
| Price To Earning | (63.38) X | 28.72 X |
| Price To Book | 0.62 X | 9.51 X |
| Price To Sales | 0.40 X | 11.42 X |
| Revenue | 425.17 M | 9.43 B |
| Gross Profit | 276.37 M | 27.38 B |
| EBITDA | (78.31 M) | 3.9 B |
| Net Income | (92.21 M) | 570.98 M |
| Cash And Equivalents | 310.82 M | 2.7 B |
| Cash Per Share | 8.78 X | 5.01 X |
| Total Debt | 221.83 M | 5.32 B |
| Debt To Equity | 0.89 % | 48.70 % |
| Current Ratio | 6.65 X | 2.16 X |
| Book Value Per Share | 7.31 X | 1.93 K |
| Cash Flow From Operations | (58.83 M) | 971.22 M |
| Short Ratio | 9.16 X | 4.00 X |
| Earnings Per Share | (1.87) X | 3.12 X |
| Price To Earnings To Growth | (3.13) X | 4.89 X |
| Target Price | 7.05 | |
| Number Of Employees | 1.22 K | 18.84 K |
| Beta | 0.93 | -0.15 |
| Market Capitalization | 169.37 M | 19.03 B |
| Total Asset | 635.71 M | 29.47 B |
| Retained Earnings | (699.41 M) | 9.33 B |
| Working Capital | 447.55 M | 1.48 B |
Note: Disposition of 6063 shares by Kevin Thornal of Nevro Corp at 4.85 subject to Rule 16b-3 [view details]
Nevro Corp Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nevro . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Nevro Corp Buy or Sell Advice
When is the right time to buy or sell Nevro Corp? Buying financial instruments such as Nevro Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nevro Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run ISP Thematic Idea Now
ISP
Internet Service Providers (ISP) companies and IT providers specializing in internet technologies. The ISP theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ISP Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Nevro Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.87) | Revenue Per Share 11.404 | Quarterly Revenue Growth (0.07) | Return On Assets (0.09) | Return On Equity (0.25) |
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.